Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

PaperCitations, authors & open-access status

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 165 citations, 2024 year and hybrid oa status.